These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 35096863)
1. Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection. Vargas-Rodriguez JR; Garza-Veloz I; Flores-Morales V; Badillo-Almaraz JI; Rocha-Pizaña MR; Valdés-Aguayo JJ; Martinez-Fierro ML Front Med (Lausanne); 2021; 8():758414. PubMed ID: 35096863 [TBL] [Abstract][Full Text] [Related]
2. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management. Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
5. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629 [TBL] [Abstract][Full Text] [Related]
6. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients. Subbaram K; Ali PSS; Ali S Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090 [TBL] [Abstract][Full Text] [Related]
7. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus. Liao YH; Zheng JQ; Zheng CM; Lu KC; Chao YC J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297431 [TBL] [Abstract][Full Text] [Related]
8. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis. Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Ambrocio-Ortiz E; Pérez-Rubio G; Del Ángel-Pablo AD; Buendía-Roldán I; Chávez-Galán L; Hernández-Zenteno RJ; Ramírez-Venegas A; Rojas-Serrano J; Mejía M; Pérez-Padilla R; Guadarrama-Pérez C; Falfán-Valencia R Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451902 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 and diabetes: A bidirectional relationship. Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218 [TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality. Stafford EG; Riviere JE; Xu X; Kawakami J; Wyckoff GJ; Jaberi-Douraki M J Am Pharm Assoc (2003); 2020; 60(6):e145-e152. PubMed ID: 32561317 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors. Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19. Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756 [TBL] [Abstract][Full Text] [Related]
15. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. Seltzer S Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735 [TBL] [Abstract][Full Text] [Related]
16. Low plasma angiotensin-converting enzyme 2 level in diabetics increases the risk of severe COVID-19 infection. Zhang Y; Sun Y; Liu K; Alolga RN; Xu X; Feng G; Xiao P Aging (Albany NY); 2021 May; 13(9):12301-12307. PubMed ID: 33962399 [TBL] [Abstract][Full Text] [Related]
17. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality. Mir MM; Mir R; Alghamdi MAA; Alsayed BA; Wani JI; Alharthi MH; Al-Shahrani AM J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834450 [TBL] [Abstract][Full Text] [Related]
18. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella. Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A Front Immunol; 2020; 11():1714. PubMed ID: 32793244 [TBL] [Abstract][Full Text] [Related]
19. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain. Zhao Y; Li W; Lukiw W Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788 [TBL] [Abstract][Full Text] [Related]
20. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study. Parit R; Jayavel S Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]